Pacira BioSciences, Inc. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 14,000 | 0 | 39,237 | 25.2 K to 39.2 K (+55.47 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Grant | A | 0.00 | 14,000 | 0 | 24,887 | 10.9 K to 24.9 K (+128.59 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 47.65 | 275,000 | 13,103,750 | 275,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 33,300 | 0 | 200,209 | 166.9 K to 200.2 K (+19.95 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 47.65 | 12,000 | 571,800 | 12,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 4,800 | 0 | 12,633 | 7.8 K to 12.6 K (+61.28 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 47.65 | 31,500 | 1,500,975 | 31,500 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 12,600 | 0 | 27,447 | 14.8 K to 27.4 K (+84.87 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Grant | A | 0.00 | 14,000 | 0 | 14,000 | 0 to 14 K |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Grant | A | 0.00 | 14,000 | 0 | 28,898 | 14.9 K to 28.9 K (+93.97 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Grant | A | 0.00 | 14,000 | 0 | 24,101 | 10.1 K to 24.1 K (+138.60 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 1,260 | 0 | 59,949 | 58.7 K to 59.9 K (+2.15 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 1,260 | 0 | 17,757 | 16.5 K to 17.8 K (+7.64 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,260 | 0 | 15,671 | 14.4 K to 15.7 K (+8.74 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,260 | 0 | 6,116 | 4.9 K to 6.1 K (+25.95 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 1,260 | 0 | 11,021 | 9.8 K to 11 K (+12.91 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Grant | A | 0.00 | 1,260 | 0 | 5,976 | 4.7 K to 6 K (+26.72 %) |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Grant | A | 0.00 | 1,260 | 0 | 1,260 | 0 to 1.3 K |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
| Jun 11 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Grant | A | 0.00 | 1,260 | 0 | 7,921 | 6.7 K to 7.9 K (+18.92 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Sell | S | 46.33 | 1,447 | 67,041 | 14,898 | 16.3 K to 14.9 K (-8.85 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 46.33 | 863 | 39,984 | 10,101 | 11 K to 10.1 K (-7.87 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 47.46 | 2,025 | 96,107 | 4,856 | 6.9 K to 4.9 K (-29.43 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Sell | S | 48.70 | 2,100 | 102,270 | 6,661 | 8.8 K to 6.7 K (-23.97 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 48.61 | 5,904 | 286,993 | 10,887 | 16.8 K to 10.9 K (-35.16 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 46.33 | 2,402 | 111,287 | 16,791 | 19.2 K to 16.8 K (-12.51 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 48.49 | 1,721 | 83,451 | 166,909 | 168.6 K to 166.9 K (-1.02 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 48.08 | 15,390 | 739,951 | 168,630 | 184 K to 168.6 K (-8.36 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 46.33 | 14,314 | 663,182 | 184,020 | 198.3 K to 184 K (-7.22 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.37 | 1,752 | 84,744 | 7,833 | 9.6 K to 7.8 K (-18.28 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.33 | 879 | 40,725 | 9,585 | 10.5 K to 9.6 K (-8.40 %) |
| Jun 08 2020 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Sell | S | 46.33 | 1,489 | 68,987 | 14,847 | 16.3 K to 14.8 K (-9.11 %) |
| Jun 04 2020 | PCRX | Pacira BioSciences ... | Manning Donald C. | Chief Medical Offic ... | Option Exercise | A | 43.58 | 71,300 | 3,107,254 | 71,300 | |
| Jun 04 2020 | PCRX | Pacira BioSciences ... | Manning Donald C. | Chief Medical Offic ... | Grant | A | 0.00 | 28,500 | 0 | 28,500 | 0 to 28.5 K |